Synthesis and Screening of New 5-Substituted-1,3,4-oxadiazole-2-thioglycosides as Potent Anticancer Agents
Mamdouh A .Z. Abu-Zaied, Galal A. M. Nawwar, Randa H. Swellem, Shahinaz H. El-Sayed

Pharmacol. Pharm. Vol.3 No.2, April 25, 2012
DOI:10.4236/pp.2012.32034

Biochemical Parameters Alterations in Multiple Sclerosis: A Longitudinal Study and Review of the Literature
Nicola Salvatore Orefice, Olga Ferraro, Francesco Barbato, Antonio Carotenuto, Roberta Lanzillo, Vincenzo Brescia Morra, Giovanni Coppola, Giuseppe Orefice

Pharmacol. Pharm. Vol.3 No.2, April 25, 2012
DOI:10.4236/pp.2012.32033

Investigations on the Significance of Inductable Cyclooxygenase in Atherogenesis in Cholesterol-Fed Rabbits
Marion Wurr, Ingo Nolte, Dirk Stichtenoth

Pharmacol. Pharm. Vol.3 No.2, April 25, 2012
DOI:10.4236/pp.2012.32032

Can Purified Omega-3 Polyunsaturated Fatty Acids Supplementation Act Blood Pressure Levels in Untreated Normal-High Blood Pressure Subjects with Hypertriglyceridemia?
Maria Leonarda De Rosa

Pharmacol. Pharm. Vol.3 No.2, April 25, 2012
DOI:10.4236/pp.2012.32031

Protective Effects of Danggui Buxue Tang on a Human Umbilical Vein Endothelialcell Damage Induced by Advanced Glycation End Products
Wenyu Qin, Bao He, Yu Bei, Rushang Wang, Lang Feng, Youhua Xu, Jiaxiao Zhu, Zhaoguang Zheng, Quan Zhu, Hong Nie

Pharmacol. Pharm. Vol.3 No.2, April 25, 2012
DOI:10.4236/pp.2012.32030